$0.78
▲ $0.04 (+5.8%)
TCRX
TScan Therapeutics Inc. Common Stock
Health Care
Investor Score
38F
Weak rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
16
Technical
29
Fundamental
51
Growth
43
Fair Value
50
News
63
Quality
54
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.